Announced Fri, 29 May · 11:49 IST

Please find enclosed the Standalone Audited Financial Results for the FY 2025-26

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+19.3%1-day move
₹96.90
prior close
₹99.52
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.5+1.4+2.5+1.9+19.3+23.8+20.7+21.5+17.9+18.0+18.8+42.0
Up moveDown movePending
AI summary

KMC Speciality Hospitals reported audited annual results for FY 2025-26 (year ended March 31, 2026). Revenue from operations grew ~35% to ₹8,225.31 lakh from ₹6,093.48 lakh in the prior year. Profit after tax rose ~20% to ₹1,757.12 lakh from ₹1,464.19 lakh. EBITDA stood at ₹6,302.36 lakh. The Q4 FY26 figures are balancing figures between audited full-year and previously published nine-month (Q3 YTD) numbers, which were subject to limited review. Auditors Deloitte Haskins & Sells issued an unmodified (clean) opinion on the annual financial statements. The company operates in a single segment — Medical and Healthcare Services.

Likely market impact

Strong top-line and bottom-line growth with clean audit opinion is positive for shareholders. Revenue growth of ~35% significantly outpaces typical industry growth, indicating market share gains or improved capacity utilisation at the company's hospital facilities in Trichy and Chennai.